Clinical Scorecard: FDA Approves Cefepime-Zidebactam Injection
At a Glance
| Category | Detail |
|---|---|
| Condition | |
| Key Mechanisms | Combination of a fourth-generation cephalosporin and a non-beta-lactam antibacterial with a beta-lactamase inhibitor, acting synergistically on multiple penicillin-binding proteins (source: Wockhardt). |
| Target Population | |
| Care Setting |
Key Highlights
- Cefepime and zidebactam achieved a composite clinical cure and microbiologic response rate of 89% at test-of-cure visit.
- Approval based on phase 3 ENHANCE-1 trial involving 530 patients across multiple countries.
- Treatment was generally well tolerated.
Guideline-Based Recommendations
Diagnosis
- Diagnosis of cUTI and acute pyelonephritis based on clinical presentation and microbiological testing (source: Wockhardt).
Management
- Cefepime and zidebactam indicated for treatment of cUTI caused by susceptible strains (source: Wockhardt).
Monitoring & Follow-up
- Monitor for clinical response and potential adverse effects during treatment (source: Wockhardt).
Risks
- Increased risk of life-threatening complications in patients with multidrug-resistant bacterial infections (source: Wockhardt).
Patient & Prescribing Data
Adults with complicated urinary tract infections caused by susceptible Gram-negative pathogens.
Cefepime and zidebactam is effective against strains of Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterobacter cloacae complex, and Pseudomonas aeruginosa.
Clinical Best Practices
- Utilize cefepime and zidebactam for patients with infections caused by susceptible Gram-negative pathogens (source: Wockhardt).
- Consider the history of antimicrobial resistance when prescribing (source: Wockhardt).
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
